Cargando…
Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness
PURPOSE: Myotonic dystrophy type 1 (DM1) is often characterized by excessive daytime sleepiness (EDS) and sleep-onset rapid eye movement periods caused by muscleblind-like protein 2. The EDS tends to persist even after treatment of sleep apnea. We measured the cerebrospinal fluid (CSF) orexin levels...
Autores principales: | Omori, Yuki, Kanbayashi, Takashi, Imanishi, Aya, Tsutsui, Ko, Sagawa, Yohei, Kikuchi, Yuka S, Takeshima, Masahiro, Yoshizawa, Kazuhisa, Uemura, Sachiko, Shimizu, Tetsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810517/ https://www.ncbi.nlm.nih.gov/pubmed/29445282 http://dx.doi.org/10.2147/NDT.S158651 |
Ejemplares similares
-
Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
Publicado: (2018) -
Sleep-Wake Cycle and Daytime Sleepiness in the Myotonic Dystrophies
por: Romigi, A., et al.
Publicado: (2013) -
Editorial: Hypocretins/Orexins
por: López, Miguel, et al.
Publicado: (2020) -
Residual effects of eszopiclone and placebo in healthy elderly subjects: a randomized double-blind study
por: Takahashi, Jun, et al.
Publicado: (2017) -
Cerebrospinal Fluid Hypocretin-1 (Orexin-A) Level Fluctuates with Season and Correlates with Day Length
por: Boddum, Kim, et al.
Publicado: (2016)